Potential of the cell-free blood-based biomarker uroplakin 2 RNA to detect recurrence after surgical resection of lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer, and ~30% of patients with LUAD develop cancer recurrence after surgery. The present study aimed to identify and validate biomarkers that may be used to monitor recurrence following LUAD surgery. Data from patients with LUAD were d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ji, Lu, Qijue, Li, Bin, Li, Huafei, Wu, Cong, Li, Chunguang, Jin, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130048/
https://www.ncbi.nlm.nih.gov/pubmed/34025787
http://dx.doi.org/10.3892/ol.2021.12781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130048/
https://www.ncbi.nlm.nih.gov/pubmed/34025787
http://dx.doi.org/10.3892/ol.2021.12781

Ejemplares similares